Abstract
BackgroundGradually increasing the interval between doses (or reducing the doses) of anti-TNF drugs does not appear to increase the risk of relapse or progression among patients with established rheumatoid arthritis...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have